PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1698
https://www.valueinhealthjournal.com/article/S1098-3015(11)03260-8/fulltext
Title :
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03260-8&doi=10.1016/j.jval.2011.08.1698
First page :
A565
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1625